Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 10 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 10

From: "Sinopharm", "Oxford-AstraZeneca", and "Pfizer-BioNTech" COVID-19 vaccinations: testing efficacy using lung CT-volumetry with comparative analysis of variance (ANOVA)

Fig. 10

A 53-year-old female patient with history of operated bilateral breast cancer and had received “Sinopharm” vaccine then got COVID-19 infection. A Axial, and B Coronal chest CT cuts (lung window) showed bilateral wide spread large heterogeneous ground-glass patches with consolidative changes and minimal right pleural collection. Breast implants are also noticed in axial cuts. C CT-Volumetry of the pathological lung parts averages 1561 cc. D CT-Volumetry of total lung volume averages 1992 cc. So, 78% of the lung parenchyma was diseased (Score 4)

Back to article page